• DAPI Nuclear Stain Solution: Practical Protocol

  2026-08-19

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution K2402 provides a ready-to-use fluorescent DNA stain for nuclear visualization and endpoint assessment of membrane integrity. It is intended mainly for fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, not as a default stain for intact live-cell imaging.

• SU 5402: From RTK Biology to Human Neuron Models

  2026-08-18

  SU 5402 offers translational researchers a way to interrogate receptor tyrosine kinase signaling across cancer biology and emerging human sensory-neuron models. This thought-leadership guide connects FGFR3-linked multiple myeloma research with rigorous pathway validation, assay design, competitive positioning, and responsible cross-domain interpretation.

• N1-Methylpseudouridine for mRNA Workflows

  2026-08-18

  N1-Methylpseudouridine supports high-output mRNA expression while helping researchers investigate innate immune and eIF2α-linked translational constraints. This practical guide connects formulation, cell-based screening, metabolic controls, and troubleshooting for more reproducible research workflows.

• G-Quadruplexes Modulate TDP43 Aggregation and Toxicity

  2026-08-17

  Oldani et al. show that RNA G-quadruplexes influence TDP-43 aggregation, intracellular distribution, and toxicity across biochemical and cellular models. The work provides a mechanistic basis for studying nucleic-acid structure as a modulator of protein misfolding, while also defining important limits for translating G-quadruplex ligands into neurodegeneration research.

• Cabozantinib: Time-Resolved Signaling in RCC

  2026-08-17

  Cabozantinib (XL184) is more than a multi-kinase inhibitor: its cellular effects change with exposure duration. This evidence-focused guide shows how to separate acute target suppression from chronic phosphorylation remodeling, motility adaptation, and assay-specific interpretation in cancer research.

• DeferoxamineB as an Iron-Death Assay Control

  2026-08-16

  DeferoxamineB is more than an iron chelator: it is a mechanistic control for separating iron-dependent lipid damage from copper-driven and other regulated cell-death signals. This article explains how to integrate Deferoxamine into cancer assays, interpret rescue experiments, and avoid confounding antiproliferative, apoptotic, and autophagic effects.

• Tankyrase Inhibition and Hippo Signaling in HCC

  2026-08-15

  Jia et al. show that the tankyrase inhibitors XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity and increasing the Hippo-pathway regulators AMOTL1 and AMOTL2. The study extends tankyrase biology beyond canonical Wnt signaling and provides a mechanistic basis for combining tankyrase inhibition with MEK or AKT pathway blockade.

• Colistin–Gamithromycin Synergy in P. multocida

  2026-08-15

  Li and colleagues showed that combining colistin with gamithromycin can markedly improve activity against Pasteurella multocida, particularly isolates with elevated colistin MICs, in a neutropenic murine pneumonia model. The study links combination efficacy to exposure-based pharmacokinetic/pharmacodynamic analysis and identifies a potentially dose-sparing strategy, while also showing that synergy depends on the bacterial isolate.

• Lipo3K Transfection Reagent for MDR Assays

  2026-08-14

  Discover how Lipo3K Transfection Reagent can support mechanistic gene expression studies and RNA interference research in paclitaxel-resistant breast cancer models. This article translates lipid-mediated delivery into a rigorous assay strategy for testing transporter cooperation, cholesterol-dependent resistance, and causal rescue.

• Canagliflozin for Renal Mitochondrial Research

  2026-08-13

  Canagliflozin enables a practical bridge between renal glucose handling and mitochondrial phenotyping in diabetic kidney models. This workflow combines SGLT2 target engagement, albuminuria, mitochondrial network imaging, and bioenergetics to distinguish glucose-lowering effects from broader proximal tubular protection.

• Cyanine 3 Tyramide for Claustrum Gene Mapping

  2026-08-13

  Cyanine 3 Tyramide enables localized signal amplification for low-abundance gene and protein targets in difficult mammalian brain sections. This workflow-focused guide translates comparative claustrum findings into practical in situ hybridization, immunohistochemistry, multiplexing, and flow cytometry strategies.

• Intravesical p21 mRNA–LNP Therapy in Bladder Cancer

  2026-08-13

  The reference study develops a nonviral tumor suppressor replacement strategy in which chemically modified p21 mRNA is packaged in lipid nanoparticles and administered directly into the bladder. The approach restored nuclear p21 expression, inhibited tumor growth in an orthotopic mouse model, and produced strong bladder-localized expression with limited transient systemic distribution.

• Dicloxacillin Activity Inside and Outside Cells

  2026-08-12

  The reference study combined THP-1 cell and murine peritonitis models to compare dicloxacillin activity against intracellular and extracellular Staphylococcus aureus. Its key contribution was showing that free-drug exposure above the MIC, rather than peak concentration or total exposure alone, best predicted efficacy in both compartments.

• E-64d Workflows for Calpain and Cathepsin Research

  2026-08-12

  E-64d provides cell-permeable, irreversible inhibition of calpain and several intracellular cysteine proteases, making it useful for separating protease-dependent events from broader cell-death phenotypes. This practical guide covers stock preparation, live-cell workflows, lysoptosis-oriented assay design, troubleshooting, and applications spanning platelets, apoptosis, neuroprotection, and cancer research.

• Ciclesonide: From Lung Activation to Translational Strategy

  2026-08-11

  Ciclesonide illustrates how prodrug activation, glucocorticoid receptor pharmacology, and tissue-relevant assay design can strengthen respiratory translational research. This article also places its evidence beside the emerging ERAD-engaging chimera platform while clearly separating established anti-inflammatory biology from an unvalidated protein-degradation hypothesis.

445 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page